2-Oxoglutarate (2OG)-dependent oxygenases have important roles in the regulation of gene expression via demethylation of N-methylated chromatin components 1,2 and in the hydroxylation of transcription factors 3 and splicing factor proteins 4 . Recently, 2OG-dependent oxygenases that catalyse hydroxylation of transfer RNA 5-7 and ribosomal proteins 8 have been shown to be important in translation relating to cellular growth, T H 17-cell differentiation and translational accuracy 9-12 . The finding that ribosomal oxygenases (ROXs) occur in organisms ranging from prokaryotes to humans 8 raises questions as to their structural and evolutionary relationships. In Escherichia coli, YcfD catalyses arginine hydroxylation in the ribosomal protein L16; in humans, MYC-induced nuclear antigen (MINA53; also known as MINA) and nucleolar protein 66 (NO66) catalyse histidine hydroxylation in the ribosomal proteins RPL27A and RPL8, respectively. The functional assignments of ROXs open therapeutic possibilities via either ROX inhibition or targeting of differentially modified ribosomes. Despite differences in the residue and protein selectivities of prokaryotic and eukaryotic ROXs, comparison of the crystal structures of E. coli YcfD and Rhodothermus marinus YcfD with those of human MINA53 and NO66 reveals highly conserved folds and novel dimerization modes defining a new structural subfamily of 2OGdependent oxygenases. ROX structures with and without their substrates support their functional assignments as hydroxylases but not demethylases, and reveal how the subfamily has evolved to catalyse the hydroxylation of different residue side chains of ribosomal proteins. Comparison of ROX crystal structures with those of other JmjCdomain-containing hydroxylases, including the hypoxia-inducible factor asparaginyl hydroxylase FIH and histone N e -methyl lysine demethylases, identifies branch points in 2OG-dependent oxygenase evolution and distinguishes between JmjC-containing hydroxylases and demethylases catalysing modifications of translational and transcriptional machinery. The structures reveal that new protein hydroxylation activities can evolve by changing the coordination position from which the iron-bound substrate-oxidizing species reacts. This coordination flexibility has probably contributed to the evolution of the wide range of reactions catalysed by oxygenases.
2-Oxoglutarate (2OG)-dependent oxygenases have important roles in the regulation of gene expression via demethylation of N-methylated chromatin components 1, 2 and in the hydroxylation of transcription factors 3 and splicing factor proteins 4 . Recently, 2OG-dependent oxygenases that catalyse hydroxylation of transfer RNA [5] [6] [7] and ribosomal proteins 8 have been shown to be important in translation relating to cellular growth, T H 17-cell differentiation and translational accuracy [9] [10] [11] [12] . The finding that ribosomal oxygenases (ROXs) occur in organisms ranging from prokaryotes to humans 8 raises questions as to their structural and evolutionary relationships. In Escherichia coli, YcfD catalyses arginine hydroxylation in the ribosomal protein L16; in humans, MYC-induced nuclear antigen (MINA53; also known as MINA) and nucleolar protein 66 (NO66) catalyse histidine hydroxylation in the ribosomal proteins RPL27A and RPL8, respectively. The functional assignments of ROXs open therapeutic possibilities via either ROX inhibition or targeting of differentially modified ribosomes. Despite differences in the residue and protein selectivities of prokaryotic and eukaryotic ROXs, comparison of the crystal structures of E. coli YcfD and Rhodothermus marinus YcfD with those of human MINA53 and NO66 reveals highly conserved folds and novel dimerization modes defining a new structural subfamily of 2OGdependent oxygenases. ROX structures with and without their substrates support their functional assignments as hydroxylases but not demethylases, and reveal how the subfamily has evolved to catalyse the hydroxylation of different residue side chains of ribosomal proteins. Comparison of ROX crystal structures with those of other JmjCdomain-containing hydroxylases, including the hypoxia-inducible factor asparaginyl hydroxylase FIH and histone N e -methyl lysine demethylases, identifies branch points in 2OG-dependent oxygenase evolution and distinguishes between JmjC-containing hydroxylases and demethylases catalysing modifications of translational and transcriptional machinery. The structures reveal that new protein hydroxylation activities can evolve by changing the coordination position from which the iron-bound substrate-oxidizing species reacts. This coordination flexibility has probably contributed to the evolution of the wide range of reactions catalysed by oxygenases.
To investigate the structural basis of catalytic differences within the ROX subfamily of JmjC-domain-containing hydroxylases and their relationship with the JmjC-containing histone N e -methyl lysine demethylases (KDMs, Fig. 1a ), we conducted structural analyses on both prokaryotic (initially YcfD from E. coli (EcYcfD) and subsequently that from the thermophile R. marinus (RmYcfD)) and human ROXs (MINA53 and NO66 183-641 ). We used RmYcfD to obtain a YcfD substrate structure. All four ROXs show marked similarities in their folds: the JmjC domain is followed by helical dimerization and carboxy-terminal 'winged helix' (WH) domains 13 (Fig. 1b) . The ROX JmjC domains consist of 11-12 b-strands, 8 of which (I-VIII) form a double-stranded b-helix (DSBH), which is stereotypical of 2OG-dependent oxygenases 14, 15 (Fig. 1c and Extended Data Fig. 1 ).
The dimerization domains have a two-fold symmetry and comprise a bundle of three a-helices (Extended Data Fig. 2 ); the dimers are stabilized by electrostatic and hydrogen bonding as well as hydrophobic interactions. Consistent with a catalytic role for this domain, dimerization blocking substitutions, EcYcfD(I211R) and MINA53(R313E) decrease activity. Hydrogen-bonding and electrostatic interactions are substantially more important in RmYcfD dimerization than for the other ROXs, consistent with the increased occurrence of electrostatic interactions in thermophiles 16 . The ROX C-terminal domains, which are required for activity (Extended Data Fig. 3 ), are reminiscent of WH domains involved in protein-protein and protein-nucleic-acid interactions 13 ; however, their overall negative charge suggests that they may not directly bind nucleic acids. In contrast to ROXs, other JmjC-containing hydroxylases-FIH 17 , tRNA yW-synthesizing protein 5 (TYW5) 6 , JmjC-domain-containing protein 4 (JMJD4) 9 , JMJD5 (ref. 18 ) and JMJD6 (ref. 4)-and KDMs, do not contain a WH domain (Fig. 2) . The combined structures led to the proposal that the ROX fold evolved into those of JmjC-containing hydroxylases and KDMs partly via loss of the WH domain, which enabled the C-terminal helical bundle to take on other roles as in KDMs or the dimerization mode as observed in FIH 17 .
ROX structures were determined in complex with Mn(II) and 2OG or N-oxalylglycine (NOG), replacing Fe(II) and 2OG. As for most 2OGdependent oxygenases, the metal is octahedrally coordinated by a 2-His-1-carboxylate triad from DSBH bII and bVII 14, 15 (Fig. 3) ; two coordination sites are occupied by the 2OG/NOG oxalyl group, leaving one for H 2 O/O 2 binding ( Fig. 4 and Extended Data Fig. 4 ). With the YcfDs, the NOG C5 carboxylate is positioned to salt bridge with EcYcfD Arg 140 or RmYcfD Arg 148 on DSBH bIV (Extended Data Fig. 4 ). This arrangement is notable because with other 2OG-dependent oxygenases in which the 2OG C5 carboxylate interacts with an Arg residue, it is located on bVIII 14, 15 . In human ROXs, the 2OG C5-carboxylate-interacting residue is a lysine (MINA53 Lys 194, NO66 Lys 355) from bIV, as in most JmjC-containing hydroxylases and KDMs. These observations suggest that eukaryotic JmjC-containing hydroxylases and KDMs evolved from prokaryotic ROXs.
Initial attempts to obtain substrate complexes by co-crystallization/ soaking crystals were unsuccessful. We therefore pursued alternatives, one involving using a thermostable YcfD homologue, which we considered may have a relatively low substrate dissociation constant (K d ), enabling complex crystallization. RmYcfD (which has 31% identity with EcYcfD) catalyses L16 fragment (20-residue peptide, amino acids Lys 72-Glu 91) Arg 82 hydroxylation with an approximately sevenfold lower Michaelis constant (K m ) than EcYcfD (268 mM and 1.9 mM, respectively). A RmYcfD-L16 72-91 structure, obtained by co-crystallization, was solved by molecular replacement using the apo EcYcfD structure (Protein Data Bank (PDB) accession 4CCL). The overall EcYcfD and RmYcfD structures are similar (Ca root mean squared deviation (r.m.s.d.) 1.58 Å ); L16 residues Lys 77-Lys 85 are visible in the electron density map (Fig. 3c ).
For the human ROXs, we used electrospray ionization-mass spectrometry guided disulphide crosslinking 19, 20 to obtain substrate complexes (Extended Data Fig. 5 ). Structures were obtained for wild-type NO66-RPL8(G220C) (complex 1), NO66(L299C/C300S)-RPL8(G220C) (complex 2) and NO66(S373C)-RPL8(G214C) (complex 3) pairs. Electron density corresponding to RPL8 residues 215-223 (complex 1), 213-223 (complex 2) and 212-223 (complex 3) was observed at the active site ( Fig. 3b and Extended Data Fig. 5 ). The RPL8 residues (215-219)including the hydroxylated His 216-adopt near identical conformations (Ca r.m.s.d., 0.29-0.36 Å ), implying that all three structures represent catalytically functional complexes (Extended Data Fig. 5 ). In the light of the NO66-RPL8 structures, we identified a MINA53 residue (Tyr 209) suitable for crosslinking: MINA53(Y209C) crystallized in complex with RPL27A(G37C) with electron density observed for RPL27A residues 36-44 ( Fig. 3a ). Further validation of the functional relevance of the crosslinked structures comes from comparisons with the wildtype RmYcfD-L16 structure and kinetic studies demonstrating activities with most variants (Extended Data Fig. 6 ).
MINA53 and NO66 bind their RPL27A and RPL8 substrates in a conserved manner (Ca r.m.s.d., RPL27A [38] [39] [40] [41] [42] [43] , RPL8 215-220 , 0.8 Å ). Comparison of human ROX and RmYcfD complexes reveals similarities in substrate binding, particularly for the hydroxylated residue and for substrate residues to the amino-terminal side of the hydroxylated residue. In all ROX complexes, substrates bind with the same N/C directionality, as observed for FIH 17 and for one KDM-plant homeodomain finger 8 (PHF8) 21 (and probably other KDM2/7 subfamily members)-but differing from that for most KDMs (KDM4A 22 , KDM6B 23 and KDM6A 24 ) ( Fig. 2 ). The substrates bind in shallow channels on the ROX surfaces and form multiple interactions/hydrogen bonds with residues from DSBH bI, bII and bVIII, and the extended bIV-bV loop. Although the N-terminal regions of RPL27A (amino acids [36] [37] [38] [39] , RPL8 (213-216) and L16 (78-81) bind similarly, the C-terminal regions of RPL27A (40) (41) (42) (43) (44) and RPL8 (217-223) form more extensive interactions with human ROXs than does L16 (83-85) with RmYcfD ( Fig. 3 ). Notably, both RPL27A and RPL8 substrates make hydrophobic contacts with the WH domains in MINA53 and NO66 (Extended Data Fig. 3 ). In addition, MINA53 forms a catalytically important salt-bridge interaction between RPL27A Arg 42 and MINA53 Asp 333 located on the a-helix connecting the dimerization and WH domains (Extended Data Figs 6 and 7) .
The general binding mode of the hydroxylated residues is conserved between prokaryotic and human ROXs, that is, they bind in deep pockets and the positions of the hydroxylated b-methylenes nearly superimpose ( Fig. 4 ). There are, however, clear differences in the way human ROXs and RmYcfD bind their target residue side chains ( Fig. 3 ). With human ROXs, the binding of RPL27A His 39/RPL8 His 216 involves a series of hydrogen bonds to backbone amides or side chains of human ROX residues: MINA53 Gln 136/NO66 Arg 297; MINA53 Asn 165/NO66 Asn 326; MINA53 Tyr 167/NO66 Tyr 328; and MINA53 Ser 257/NO66 Ser 421 ( Fig. 3a, b ). With RmYcfD, the Arg 82 'slots' into a hydrophobic cleft defined by RmYcfD Tyr 137 and Met 120 side chains and hydrogen bonds to RmYcfD Asp 118 and Ser 208 ( Fig. 3c ). Mutagenesis studies on ROXs support the observed binding modes of the substrate residues (Extended Data Figs 6 and 8 ).
There are conflicting reports as to the catalytic activities of some JmjC-containing hydroxylases, including NO66, which has been classified as both a hydroxylase 8 and a KDM 25 . Comparison of ROXs with KDMs and FIH (Figs 2 and 4a) identifies distinctive structural features characteristic of JmjC-containing hydroxylases and KDMs, in addition to the roles of the WH domains. This is important because it supports the assignment of hydroxylase (but not demethylase) activities for ROXs and other human JmjC-containing hydroxylases; for example, FIH 17 and JMJD6 (ref. 4) . In our assays with isolated MINA53 and NO66 we have consistently not observed enzyme-catalysed demethylation under conditions in which JmjC-containing KDMs are active 8 . Although we cannot rule out the possibility that some of the JmjC-containing hydroxylases may have KDM activities under different conditions or in cells, the multiple structures reported here suggest that for this to occur, substantial active-site rearrangements would be required on substrate binding. In Domain architecture and a schematic representation of the DSBH core b-strands (bI-VIII) that form major (blue, bI, VIII, III and VI) and minor sheets (grey, bII, VII, IV and V) is shown boxed. The insert between bIV and bV (purple) is involved in substrate binding. The three Fe-coordinating residues are on the bII and bVII strands (black circles). 2OG is in green sticks; the 2OG C5-carboxylate-binding residue, Arg (YcfDs) or Lys (human ROXs) from bIV is a black circle. 
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ROXs and KDM4A-H3K9me2 (PDB accession 2OX0) 22 complex structures, the different substrates bind with 'opposite' N-to-C directionalities with respect to the catalytic machinery. The histone K9me n side chain is positioned similarly to the ROX-hydroxylated residue side chains; however, because KDM-catalysed hydroxylations occur at N emethyl lysine-residue termini, their target residues do not penetrate as far into the enzyme active site (Fig. 4a ). The ROXs also lack two flexible loops linking a4-bI (amino acids 164-175) and a9-a10 (amino acids 302-317) in KDM4A, which are conserved in KDMs [21] [22] [23] [24] and which form important interactions with the Kme n side chain, illustrating how the 'core' ROX fold has been modified by evolution to accommodate the Kme n side chain.
Like ROXs, FIH catalyses b-hydroxylation of an Asn residue in its HIF-a transcription factor substrate 17 and of other residues, including histidines in ankyrins 26 . Superimposition of human ROX and FIHsubstrate structures is interesting from catalytic and evolutionary perspectives. Although both FIH and human ROXs catalyse histidine 3S hydroxylation, the positions of their substrate imidazoles is markedly different ( Fig. 4 and Extended Data Fig. 9 ). The positioning of hydroxylated methylenes relative to the metal differs substantially: in the overlaid structures, the angle between the metal and the Cb atoms of the RPL27A His 39/RPL8 His 216 (human ROX substrate) and HIF-1a Asn 803 (FIH substrate) is ,50u ( Fig. 4 and Extended Data Fig. 9 ), demonstrating that the reactive oxidizing intermediates (Fe(IV)5O) 15, 27 react from different coordination positions in different oxygenases. Studies with 2OG-dependent halogenases have led to the proposal that iron-bound reactive intermediates abstract a hydrogen from the substrate and deliver a halogen or hydroxyl from different coordination positions to form products 28 . In contrast, our work implies flexibility in the coordination positions with respect to the hydrogen abstracted in different JmjCcontaining hydroxylases from which the ferryl-oxo reacts. Together with other structural considerations, this observation has consequences for the evolution of the JmjC-containing oxygenases.
RPL8 (NO66 substrate) has an Asn at the 21 position relative to the hydroxylated His 216 (YcfD/MINA53 substrates have hydrophobic residues at the analogous positions). The RPL8 Asn 215 methylene is only slightly (0.5 Å ) further from the metal than that of RPL8 His 216, revealing the extreme sensitivity of oxygenase catalysis to geometric positioning. There is a notable correlation in the binding of RPL8 Asn 215 and HIF-1a Asn 803 to NO66 and FIH, respectively, even though one residue is LETTER RESEARCH hydroxylated and one is not; the primary amides of both RPL8 Asn 215 and HIF-1a Asn 803 hydrogen bond with primary amides, that is, NO66 Asn 376 and FIH Gln 239. Collectively these observations reveal that 2OG-dependent oxygenases can evolve new activities not only by 'directly' altering the nature of enzyme-substrate interactions (including by altering the directionality of substrate binding), but also by changing the coordination position from which the ferryl intermediate reacts.
The combined structures reveal that the observed modes of ROX hydroxylations have probably evolved into those of other JmjC-containing hydroxylases and the KDMs, both by altering the coordination position from which the ferryl-oxo reacts and by engineering the depth of substrate penetration. Structurally informed phylogenetic analyses (Extended Data Fig. 10 ), coupled to the observation that NO66 is more widely distributed than FIH and MINA53, reveal that prokaryotic YcfDs evolved into NO66, which is a branch point leading to the eukaryotic JmjCcontaining hydroxylases and demethylases. 2OG-dependent oxygenases are among the most catalytically flexible of all enzyme families. Recent work has revealed that FIH manifests remarkable catalytic promiscuity, including the ability to oxidize Asn and His residues 29 . Our structural studies reveal that ROXs react with substrates through a different but evolutionarily related binding mode to FIH. The catalytic capabilities of 2OG-dependent oxygenases for protein oxidations thus probably extend beyond those presently identified.
METHODS SUMMARY
Recombinant human MINA53 and NO66 and bacterial EcYcfD and RmYcfD were produced in E. coli and purified by metal affinity/cation exchange and size-exclusion chromatography. Assays comprised incubation with Fe(II), 2OG and substrate followed by mass spectrometry and/or 2OG turnover assays. Crystals were grown by vapour diffusion ( Supplementary Table 1 ) and cryo-cooled in liquid nitrogen. Data were collected on Swiss Light Source X10SA, European Synchrotron Radiation Facility BM16 and Diamond Light Source MX beamlines. MINA53 and EcYcfD structures were solved by single-wavelength anomalous diffraction or by single isomorphous replacement with anomalous scattering using SeMet derivatives. The 
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METHODS
Recombinant protein production and enzyme assays. Complementary DNA sequences encoding N-terminally truncated MINA53 (amino acids 26-465) and NO66 (amino acids 183-641) were PCR amplified from the Mammalian Gene Collection (MGC; accession numbers BC014928 and BC011350, respectively) and cloned into pNIC28-Bsa4 vector. Full-length EcYcfD was cloned into pET-28a(1) vector (Novagen) as previously described 8 . The RmycfD gene (NCBI gene accession number 8566662) was amplified by PCR from genomic DNA of R. marinus, and was cloned into pGEM-T Easy Vector and then into pET-28a(1). Stratagene's QuickChange site-directed mutagenesis kit was used to make all ROX mutations using the above constructs as templates.
Wild-type ROX enzymes/variants were produced as native His 6 -tagged proteins in E. coli BL21(DE3) as described 8 . For crystallization experiments, selenomethionine (SeMet)-derivatized enzymes, SeMet-MINA53 and SeMet-EcYcfD, were produced in E. coli BL21(DE3)-R3-pRARE2 and BL21(DE3) strains, respectively. In general, cells were grown in Le Master media 31 (alternatively in SelenoMethionine Medium Base plus Nutrient Mix) supplemented with SeMet (40-50 mg ml 21 ) and kanamycin (30 mg ml 21 ) at 37 uC (while shaking at 200 r.p.m.) until an optical density at 600 nm (OD 600 nm ) of 1.2 (SeMet-MINA53) or 0.6 (SeMet-EcYcfD) was reached. Protein expression was then induced with 0.2 mM (SeMet-MINA53) or 1.0 mM (SeMet-EcYcfD) isopropyl-b-D-thiogalactoside (IPTG) and allowed to continue for 18 h at 18 uC. All native/SeMet-derivatized proteins were purified from cell lysates using immobilized Ni 21 affinity chromatography with gradient elution using imidazole and/or ion-exchange chromatography. For YcfDs, imidazole was removed by buffer exchange to 50 mM HEPES-Na pH 7.5 using a PD10 desalting column followed by a further purification using Q-Sepharose HP (EcYcfD) or SourceQ 16 (RmYcfD) anion exchange chromatography. For MINA53 and NO66, the His 6 tag was removed by incubation with TEV protease followed by a final-step purification using size-exclusion chromatography in 50 mM HEPES-Na pH 7.5, 500 mM NaCl, 5% (v/v) glycerol, 0.5 mM tris(2-carboxyethyl)phosphine (TCEP). Proteins were concentrated to 10-30 mg ml 21 and were of .95% purity, as determined by SDS-PAGE. All columns were supplied by GE Healthcare. Assays were performed as described 8 . Crystallization, data collection and processing. Crystals of MINA53, NO66, EcYcfD and RmYcfD complexes were grown as described in Supplementary Table 1 . In general, crystals were cryoprotected by transferring to a solution of mother liquor supplemented with 20% (v/v) ethylene glycol (MINA53/NO66) or 25% (v/v) glycerol (YcfDs) before being cryo-cooled in liquid nitrogen.
As described in Supplementary Tables 2-4 , data on native and SeMet-derivatized crystals were collected at 100 K using synchrotron radiation at the Swiss Light Source (SLS) beamline X10SA, European Synchrotron Radiation Facility (ESRF) beamline BM16 and Diamond Light Source (DLS) beamlines. The data were processed as outlined in Supplementary Tables 2-4 . Structure solution and refinement MINA53 structures. SHAKE-AND-BAKE 32 was used to identify five Se positions in the SeMet-MINA53-NOG data set (P4 3 32 space group); refinement of heavy atom parameters and phasing was carried out with SHARP 33 using the single isomorphous replacement with anomalous scattering (SIRAS) method with MINA53-NOG (native) as the native and SeMet-MINA53 as the derivative data set (Supplementary Table 2 ). The electron density map after density modification with SOLOMON 34 was of good quality; automated model building with ARP/wARP resulted in a .80% complete model with one MINA53 molecule per asymmetric unit, which corresponds to an unusually high solvent content of ,75%. Refinement was carried out with BUSTER 35 and after several cycles of manual rebuilding with COOT 36 , the model converged to 19.7% R cryst and 22.9% R free . Atomic coordinates and structure factors for this structure are deposited in the PDB database under the accession number 2XDV.
SeMet-MINA53-2OG structure was solved by using phases from a highly redundant single-wavelength anomalous dispersion (SAD) data set collected around the Se absorption edge. Using Patterson seeding and dual-space direct methods, SHELXD (SHELXCDE pipeline 37 /CCP4 suite 38 ) located six out of eight possible Se sites. Refinement of substructure solution followed by density modification with SHELXE 37 resulted in good-quality initial phases to 2.8 Å resolution. Automated model building with BUCCANEER 39 resulted in a model where core regions including the JmjC and dimerization domains were built. Iterative refinement using CNS 1.3 (ref. 40) and model building using COOT 36 continued until R free was around 30%. Final rounds of manual fitting using COOT 36 and refinement using a combination of CNS 1.3 (ref. 40 ) and PHENIX 41 continued until R cryst /R free no longer improved ( Supplementary Table 2 ). This structure (deposited in the PDB under accession number 4BU2) was then used as a search model to solve the structure of MINA53(Y209C) in complex with RPL27A(G37C) by molecular replacement (MR) with PHASER 42 (P2 1 2 1 2 1 space group, resolution 2.05 Å ). The quality of all MINA53 structures was validated using MOLPROBITY 43 with .95% of the residues in the favoured region of the Ramachandran plot. NO66 structures. An N-terminally truncated form of MINA53 (amino acids 30-260), comprising the JmjC domain, was used as a search model for MR using PHASER 42 . The two molecules in the asymmetric unit of NO66 were readily located, but the electron density away from the JmjC core of NO66 was ambiguous. Density modification with RESOLVE 44 , as implemented in PHENIX 41 , which took advantage of the two-fold non-crystallographic symmetry (in a P2 1 2 1 2 space group), led to a marked map improvement and allowed automated model building with BUCCANEER 39 . Refinement was carried out with REFMAC 45 ; after several cycles of manual rebuilding with COOT 36 , the model converged to 18.5% R cryst and 23.1% R free . Atomic coordinates and structure factors for this structure are deposited in the PDB under accession number 4DIQ. The remaining NO66 structures, including those in complex with substrate RPL8, were solved in P2 1 or C2 space groups (resolution 2.15-2.50 Å ) with 2-4 molecules per asymmetric unit ( Supplementary Table 3 ) using the NO66/P2 1 2 1 2 structure (PDB accession 4DIQ) as a search model. Iterative rounds of model building using COOT 36 and refinement using PHENIX 41 and/or CNS 1.3 (ref. 40) were performed until the decreasing R cryst and R free no longer converged (Supplementary Table 3 ). All residues were in acceptable regions of Ramachandran plots as calculated by MOLPROBITY 43 . YcfD structures. SOLVE was used to locate 17 out of 22 possible Se sites using the SeMet-EcYcfD data set. Eight pairs of sites were related by non-crystallographic symmetry. The initial electron density map after solvent flattening density modification with RESOLVE 44 was of good quality and automated model building resulted in a model where core regions (60% of residues in the crystallized protein's sequence) of both molecules in the asymmetric unit were built. Refinement and fitting cycles were performed using PHENIX 41 and COOT 36 that converged to a final 19.5% R cryst and R free 25.0%. Phasing and refinement statistics are summarized in Supplementary  Table 4 . Structures of RmYcfD in complex with 1-chloro-4-hydroxyisoquinoline-3-carbonyl)glycine (IOX3) (ref. 46) or substrate L16 were solved by MR using the EcYcfD structure as the search model. The structural refinement was carried out with PHENIX with iterative rebuilding of the models using COOT until R cryst /R free converged to final values (Supplementary Table 4 ). PHF8-Fe-NOG-H3K4me3K9me2 (PDB accession 3KV4) (e) and KDM4A-Ni-NOG-H3K9me2 (7) (8) (9) (10) (11) (12) (13) (14) (PDB accession 2OX0) (f) (substrates are not shown). DSBH core elements, labelled bI-bVIII, are in green, helices in cyan, additional b-strands in red, random coils in black and the insert between the fourth and fifth b-strands in blue. Note that not all the DSBH oxygenases maintain antiparallel hydrogen-bond pairing between bII and bVII even though the w/y angles (bII) are within the b-region of the Ramachandran plot. NH1-Glu 320 A Oe2, 3.2 Å ; Arg 313 B NH2-Glu 320 Oe1, 2.7 Å ; Arg 313 A NH2-Asp 317 Od1, 2.9 Å ) that connects the a2 helices of different monomers. Backbone amide hydrogen bonding additionally occurs between the NO66 residues Asn 426 and Leu 454, Arg 452 and Trp 428, Phe 450 and Gly 429. MINA53 also has backbone-to-side-chain interactions between residues from flexible loops connecting a1-a2 and a2-a3 helices (Gln 297 B O-Lys 331 A Nf, 3.7 Å ; Ser 300 B Oc-Glu 324 A O, 3.1 Å ). The role of hydrophobic/aromatic clusters in dimerization is apparent in NO66 where the a2 helices from different monomers are further apart when compared with those of YcfDs and MINA53 and hence have less buried surface area. However, in NO66, an apparent hydrophobic cluster forms between the N-terminal part of a1 and the C-terminal part of a2. NO66 Trp 428 (Trp 264 in MINA53) is positioned at the start of the a1 helix of monomer A and forms the centre of a hydrophobic cluster, interacting with residues Phe 431 A , Ile 435 A and Leu 432 A on monomer A, and Val 481 B , Leu 484 B , Met 462 B , Phe 477 B and Pro 455 B on monomer B. NO66 Trp 428 also forms an apparent cation-p interaction with residue Lys 480. The similarly positioned Trp 264 in MINA53 maintains hydrophobic contacts with Phe 267 and Leu 268 of the same monomer and with Ile 290, Pro 291 and Leu 294 of the other monomer, in addition to a cation-p interaction with Arg 307. Other hydrophobic contacts observed in MINA53 dimerization involving the a1 and a2 helices of different monomers include between the side chains of residues Leu 308/a2 (interacting with Leu 319/a2 and Phe 267, Leu 268, Thr 271 of a1), Leu 312/a2 (interacting with Ile 272/a1 and Leu 315/a2) and Phe 277/a1 (interacting with Val 276, Leu 269 and Ile 272 of a1). Disruption of ROX dimerization leads to loss of activity, as observed for MINA53(R313E) and EcYcfD(I211R) variants as well as for truncated MINA53 (1-265, 1-299) without dimerization and the C-terminal domains. Non-denaturing gel electrophoresis was used to investigate ROX oligomerization states in solution, which demonstrates disruption of dimerization in EcYcfD(I211R) and MINA53(R313E). The loss of activity via destabilizing ROX dimerization is reminiscent of similar roles of FIH dimerization in catalysis (An FIH(L340R) variant that was predominantly monomeric is inactive) 50 . Data show mean and standard error of the mean (s.e.m.) (n 5 3). In addition, in the MINA53-RPL27A complex, Leu 38 and Arg 42 of RPL27A make hydrophobic contacts with MINA53 Leu 176 and a salt-bridge interaction with MINA53 Asp 333, respectively. We produced variants of all these residues to investigate their roles on substrate binding. The results of the endpoint assays as well as kinetic studies on the variants (right panels) show that substitution of these residues causes substantial losses of activity. c, In the case of RmYcfD, the hydroxylated residue L16 Arg 82 binds in a hydrophobic cleft lined by RmYcfD Tyr 137 and RmYcfD Met 120 side chains and hydrogen bonds to RmYcfD Asp 118 and RmYcfD Ser 208. To test the crystallographically observed binding mode, variants of RmYcfD residues (Asp 118, Met 120, Tyr 137 and Ser 208, highlighted) were prepared in EcYcfD (corresponding to Asp 110, Met 112, Tyr 129 and Ser 199, respectively). Mutagenesis studies on all ROXs support the crystallographically observed binding modes of the substrate residues. The combined biochemical and structural data also provide insights into the substrate selectivity of ROXs over other oxygenases.
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